CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $34,000 | -51.4% | 173,172 | +11.8% | 0.00% | – |
| Q3 2018 | $70,000 | +11.1% | 154,915 | +23.4% | 0.00% | – |
| Q2 2018 | $63,000 | -87.7% | 125,510 | -42.7% | 0.00% | – |
| Q1 2018 | $511,000 | +3.0% | 219,225 | +25.4% | 0.00% | – |
| Q4 2017 | $496,000 | -0.8% | 174,753 | -0.1% | 0.00% | – |
| Q3 2017 | $500,000 | +17.9% | 174,864 | +1.9% | 0.00% | – |
| Q2 2017 | $424,000 | +60.6% | 171,616 | +134.9% | 0.00% | – |
| Q1 2017 | $264,000 | +169.4% | 73,062 | +165.2% | 0.00% | – |
| Q4 2016 | $98,000 | -11.7% | 27,554 | +0.6% | 0.00% | – |
| Q3 2016 | $111,000 | -56.1% | 27,402 | -52.6% | 0.00% | – |
| Q2 2016 | $253,000 | +4.5% | 57,783 | -9.5% | 0.00% | – |
| Q1 2016 | $242,000 | -97.8% | 63,816 | -90.8% | 0.00% | -100.0% |
| Q4 2015 | $10,868,000 | +68.6% | 693,119 | +13.3% | 0.00% | +33.3% |
| Q3 2015 | $6,447,000 | -56.1% | 611,730 | +5.1% | 0.00% | -50.0% |
| Q2 2015 | $14,683,000 | -30.8% | 582,215 | -23.6% | 0.01% | -25.0% |
| Q1 2015 | $21,229,000 | +109.3% | 761,706 | +37.1% | 0.01% | +100.0% |
| Q4 2014 | $10,141,000 | +40.8% | 555,676 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $7,202,000 | -32.7% | 555,676 | -15.2% | 0.00% | -25.0% |
| Q2 2014 | $10,699,000 | -8.4% | 655,546 | -0.8% | 0.00% | -20.0% |
| Q1 2014 | $11,676,000 | -32.1% | 660,767 | -7.0% | 0.01% | -28.6% |
| Q4 2013 | $17,193,000 | +1.5% | 710,187 | +48.6% | 0.01% | 0.0% |
| Q3 2013 | $16,932,000 | +2312.0% | 477,906 | +962.9% | 0.01% | – |
| Q2 2013 | $702,000 | – | 44,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |